Quantum stocks attempted a recovery Wednesday morning following weeks of steep losses, spurred by news of technical breakthroughs and the U.S. Department of Energy’s $625 million funding commitment to quantum research centers. RGTI stock is climbing. Watch the real-time price action here. The rebound was led by the biggest names, such as sector giants IonQ, Inc. (NYSE:IONQ), Rigetti Computing, Inc. (NASDAQ:RGTI), and D-Wave Quantum, Inc. (NYSE:QBTS), which saw recent retracements but appeared to be finding ...

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Varonis Systems, Inc., (“Varonis" or the "Company") (NASDAQ: VRNS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.  Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/varonis-systems-inc. The Portnoy La ...

The Supreme Court just kicking off arguments on the legality of President Trump's tariffs. Aean Javvers is outside the court and he has the latest for us. Good morning, Aman. >> Hey, good morning, David.It's going to be an enormously high stakes day here at the Supreme Court today. President Trump says he's not going to attend today's oral arguments after all, but Treasury Secretary Scott Bessant is expected to be seated in the front row. President Trump says he believes this will be one of the most importa ...

Online car marketplace Carvana has benefited from a strong used car market in 2025. New car prices have been stable for most of the year, and used car prices have also remained steady in response. Carvana Q3 results 150,941 retail units sold, +44% Revenue +55% to $5.65 billion Net Income $263 million, +$115 million year over year Record levels of retail units sold, revenue, adjusted EBITDA, and operating income As Kelley Blue Book notes, "when new car prices rise, used car prices tend to follow." ...

CEO.CA's Inside the Boardroom: Myriad Uranium Approved for 222 Holes, Grades 60% Higher Than Historic Data at Copper MountainNovember 05, 2025 11:07 AM EST | Source: CEO.CA Technologies Ltd.Toronto, Ontario--(Newsfile Corp. - November 5, 2025) -  CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers.Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popul ...

Jones Research has re-issued its ‘Hold’ rating for Bitcoin mining giant MARA (Nasdaq: MARA), noting missed expectations for third quarter earnings as higher operating costs weighed on margins. The bitcoin miner and digital infrastructure company reported third-quarter revenue of $252.4 million, up 6% from the prior quarter and above JonesResearch’s $246.1 million estimate. However, EBITDA came in at $51.0 million, below the firm’s $83.7 million projection, as general and administrative and research expens ...

Key Takeaways Corcept reported Q3 EPS of $0.16, which missed estimates and fell from $0.41 in the prior-year quarter.CORT's revenues grew 14% year over year to $207.6 million in Q3 but missed expectations.CORT cut 2025 revenue guidance to $800-$850 million, prompting a 4.6% after-hours share drop.Corcept Therapeutics (CORT) reported third-quarter 2025 earnings of 16 cents per share, which missed the Zacks Consensus Estimate of 18 cents. The company had reported earnings of 41 cents per share in the year-ago ...

U.S. crude oil stocks rose by 5.2 million barrels amid a rebound in imports, according to the Energy Information Administration. ...

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Avantor, Inc., (“Avantor” or the "Company") (NYSE: AVTR) investors off a class action on behalf of investors that bought securities between March 5, 2024 and October 8, 2025, inclusive (the “Class Period”). Fiserv investors have until December 29, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, ...

Core Insights - Teva Pharmaceutical reported adjusted earnings of 78 cents per share on $4.48 billion in third-quarter sales, surpassing analyst expectations of 68 cents per share and $4.38 billion in sales [1] - The company raised its sales guidance for the drug Austedo to $2.05 billion to $2.15 billion, while lowering the low end of its full-year sales outlook by $200 million to a range of $16.8 billion to $17 billion [2] - Teva's stock surged 12% in premarket trading, breaking out of a cup-with-handle base and returning to its buy zone [3] Financial Performance - Teva's third-quarter sales of $4.48 billion represent an increase from $4.33 billion in the same period last year [1] - The adjusted earnings guidance for the full year has been raised to a range of $2.55 to $2.65 per share, compared to analyst expectations of $2.61 per share [2] Stock Market Activity - Teva's stock price increased to $22.91 after the earnings report, indicating strong market performance [3] - The stock had previously dipped below its entry point but managed to return to the buy zone, which extends up to $20.98 [3]